Skip to main content
Clinical Trials/NCT04152642
NCT04152642
Completed
Not Applicable

A Pilot Clinical Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse Compared to a Negative Control

Procter and Gamble1 site in 1 country22 target enrollmentNovember 4, 2019
ConditionsDry Mouth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dry Mouth
Sponsor
Procter and Gamble
Enrollment
22
Locations
1
Primary Endpoint
Product Performance and Attributes (PPAQ I) Question #1: 2-hr at Day 4
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The objective of this pilot study is to determine if an experimental mouth rinse and a marketed dry mouth rinse are more effective in relieving dry mouth compared to water.

Detailed Description

This is a controlled, randomized, 3-treatment, 3-period crossover study in subjects with self-reported dry mouth symptoms as determined by subject responses (as determined by the response to "relieving the discomfort of dry mouth" question from the modified Product Performance and Attributes Questionnaire I/ Moisturization and Dryness (PPAQ I/ MD)) compared to water. Subjects enrollment is based on the responses to the Dry Mouth Inventory (DMI). A sufficient number of volunteers will be screened to ensure enrollment of up to 30 subjects at Acclimation. Subjects who meet the eligibility criteria will continue into the treatment phase of the study. Safety will be assessed by Oral examinations at Baseline/Day1 and Day 4. Subjects will complete questionnaires at Baseline (before product use Day 1 only), after immediate use, 30 minutes, 1 hour, 2 hours, and 4 hours after supervised product use on Day 1 and Day 4 of each period. The PPAQ II questionnaire will be completed in the morning of Day 4 of each period. Subjects will be randomly assigned to treatment sequences at the Baseline visit of Period 1. The treatment and washout periods will be repeated until all three treatment periods have been completed.

Registry
clinicaltrials.gov
Start Date
November 4, 2019
End Date
December 5, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Procter and Gamble
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Provide written informed consent prior to participation and be given a signed copy of the informed consent form;
  • Be at least 18 years of age;
  • Be in good general health as determined by the Investigator/designee;
  • Agree not to participate in any other oral care studies for the duration of this study;
  • Agree to delay elective dentistry, including dental prophylaxis, until study completion, and to report any non-study dentistry received during the course of the study;
  • Agree to refrain from the use of any non-study oral hygiene products for the study duration including mouth rinse and toothpaste (flossing is permitted if part of their normal routine);
  • Self-report a dry mouth feeling according to the modified DMI questions. (Subject must answer at least 2 out of 4 questions with 'agree a little,' 'agree' or 'strongly agree');
  • Agree to refrain from smoking, drinking, using tobacco products, using breath mints, medicated lozenges, or chewing gum during the 4-hour test period;
  • Agree to return for all scheduled visits and to follow all study procedures.

Exclusion Criteria

  • Any condition or disease, as determined by the Investigator/Designee, that could be expected to interfere with examination procedures, with compliance, or with the subject's safe completion of the study;
  • Severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession;
  • Active treatment for periodontitis;
  • Having a history of allergies or hypersensitivity to mouth rinse or ingredients in commercial dental products or cosmetics;
  • Self-reported pregnancy or the intent to become pregnant during the study, or breast feeding;
  • Full or partial dentures or any orthodontic appliances such as braces or aligners, or tongue or mouth piercing;
  • Having diabetes;
  • Inability to undergo any study procedure;
  • Having untreated oral mucosal disease which in the opinion of the investigator could interfere with the study (e.g., current oral ulceration);
  • Use of prescription systemic parasympathetic medications (e.g., Pilocarpine), for the treatment of the feeling of dry mouth;

Outcomes

Primary Outcomes

Product Performance and Attributes (PPAQ I) Question #1: 2-hr at Day 4

Time Frame: 2-hour, Day 4

Product Performance and Attributes (PPAQ I) Question #1: Since you have been used the product, please rate each of the following at this timepoint: (Select one response for each attribute)- excellent=5, very good=4, good=3, fair=2, poor=1: 1) Relieves the discomfort of your dry mouth

Study Sites (1)

Loading locations...

Similar Trials